Study of SC-102 in Patients With Advanced Solid Tumors

Clinical trial NCT06710158 · RECRUITING

Trial details

NCT number: NCT06710158
Sponsor: Tianjin ConjuStar Biologics Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Cancers

Start date: 2024-12-05
Primary completion: 2026-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.